← FDA Drug Approvals (Drugs@FDA)
STIVARGA
NDA · New Drug Application · Sponsor: BAYER HLTHCARE · Approved 2012-09-27
Drug application
- FDA Application #
NDA203085- Application type
- New Drug Application
- Brand name
- STIVARGA
- Generic name
- REGORAFENIB
- Active ingredients
- REGORAFENIB
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- BAYER HLTHCARE
- Manufacturer
- Bayer HealthCare Pharmaceuticals Inc.
- First approval
- 2012-09-27
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown